SCHEMBL1641823

SCHEMBL1641823

O=C(Nc1cccc(-c2ncsc2-c2ccnc(Nc3cccc(CN4CCCC4)c3)n2)c1)c1c(F)cccc1F

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 9/20 0.71
▸ BRAF P15056 2/20 0.53
▸ EGFR P00533 6/20 0.52
▸ ERBB2 P04626 6/20 0.52
▸ KDR P35968 3/20 0.52
▸ AURKB Q96GD4 3/20 0.52
▸ JAK3 P52333 2/20 0.52
▸ SRC P12931 2/20 0.52
▸ SYK P43405 2/20 0.52
▸ PRKD3 O94806 2/20 0.52
▸ MAP4K4 O95819 2/20 0.52
▸ LCK P06239 2/20 0.52
▸ FYN P06241 2/20 0.52
▸ CSF1R P07333 2/20 0.52
▸ RET P07949 2/20 0.52
▸ MAP4K2 Q12851 2/20 0.52
▸ STK3 Q13188 2/20 0.52
▸ TAOK1 Q7L7X3 2/20 0.52
▸ MAP4K5 Q9Y4K4 2/20 0.52
▸ AURKA O14965 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1641738 0.88 IGF1R (0.69) IGF1RBRAFEGFRERBB2KDR
SCHEMBL1642761 0.88 IGF1R (0.69) IGF1RBRAFEGFRERBB2KDR
SCHEMBL1641798 0.88 IGF1R (0.68) IGF1RBRAFEGFRERBB2KDR
SCHEMBL1641718 0.87 IGF1R (0.67) IGF1RBRAFEGFRERBB2KDR
SCHEMBL1641945 0.87 IGF1R (0.67) IGF1RBRAFEGFRERBB2KDR
SCHEMBL1641887 0.87 IGF1R (0.67) IGF1RBRAFEGFRERBB2KDR
SCHEMBL1640688 0.87 IGF1R (0.67) IGF1RBRAFEGFRERBB2KDR
SCHEMBL1641968 0.87 IGF1R (0.67) IGF1RBRAFEGFRERBB2KDR
SCHEMBL12726565 0.86 IGF1R (0.59) IGF1RBRAFEGFRERBB2KDR
SCHEMBL12726561 0.85 BRAF (0.54) IGF1RBRAFEGFRERBB2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110098296-A1 Thiazole And Oxazole Kinase Inhibitors GLAXOSMITHKLINE LLC 2011-04-28 — — US disclosed
US-20110098296-A1 Thiazole And Oxazole Kinase Inhibitors GLAXOSMITHKLINE LLC 2011-04-28 — — US disclosed
US-20110098296-A1 Thiazole And Oxazole Kinase Inhibitors GLAXOSMITHKLINE LLC 2011-04-28 — — US disclosed
WO-2009076140-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098296-A1 Thiazole And Oxazole Kinase Inhibitors PDXK, MAP3K1, MAP4K2 IGF1R 396/4885BRAF 151/4885EGFR 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback